{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:08:59Z","timestamp":1791054539934,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008392","name":"Sundhed og Sygdom, Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1053\/j.gastro.2013.11.009","type":"journal-article","created":{"date-parts":[[2013,11,20]],"date-time":"2013-11-20T23:19:50Z","timestamp":1384989590000},"page":"812-821.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Differential Sensitivity of 5\u2032UTR-NS5A Recombinants of Hepatitis C\u00a0Virus Genotypes 1\u22126 to Protease and NS5A Inhibitors"],"prefix":"10.1053","volume":"146","author":[{"given":"Yi-Ping","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santseharay","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl","family":"Humes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne B.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Gottwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Bukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2013.11.009_bib1","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrmicro3046","article-title":"The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection","volume":"11","author":"Bartenschlager","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"10.1053\/j.gastro.2013.11.009_bib2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ncpgasthep1274","article-title":"Interferon-based therapy for chronic hepatitis C: current and future perspectives","volume":"5","author":"Zeuzem","year":"2008","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2013.11.009_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2007.07.033","article-title":"The changing epidemiology of hepatitis C virus infection in Europe","volume":"48","author":"Esteban","year":"2008","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2013.11.009_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1478-3231.2009.02188.x","article-title":"The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report","volume":"30","author":"Antaki","year":"2010","journal-title":"Liver Int"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2013.11.009_bib5","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/S0168-8278(12)60010-5","article-title":"Antiviral strategies in hepatitis C virus infection","volume":"56","author":"Sarrazin","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2013.11.009_bib6","article-title":"Highly efficient infectious cell culture of three HCV genotype 2b strains and sensitivity to lead protease, NS5A, and polymerase inhibitors","author":"Ramirez","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2013.11.009_bib7","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1073\/pnas.1016606108","article-title":"MicroRNA-122 antagonism against hepatitis C virus genotype 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5\u2032UTR","volume":"108","author":"Li","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2013.11.009_bib8","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1053\/j.gastro.2011.06.004","article-title":"Differential efficacy of protease inhibitors against HCV genotypes 2a, 3a, 5a, and 6a NS3\/4A protease recombinant viruses","volume":"141","author":"Gottwein","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2013.11.009_bib9","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1053\/j.gastro.2010.11.036","article-title":"Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-alpha","volume":"140","author":"Scheel","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2013.11.009_bib10","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1128\/AAC.02164-12","article-title":"Combination treatment with hepatitis C virus protease and NS5A inhibitors is effective against recombinant genotype 1a, 2a, and 3a viruses","volume":"57","author":"Gottwein","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2013.11.009_bib11","doi-asserted-by":"crossref","first-page":"19757","DOI":"10.1073\/pnas.1218260109","article-title":"Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system","volume":"109","author":"Li","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2013.11.009_bib12","first-page":"E1101","article-title":"Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains","volume":"109","author":"Li","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2013.11.009_bib13","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1073\/pnas.94.16.8738","article-title":"Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee","volume":"94","author":"Yanagi","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2013.11.009_bib14","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1128\/JVI.02667-09","article-title":"Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in\u00a0vivo pathogenesis studies","volume":"84","author":"Gottwein","year":"2010","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2013.11.009_bib15","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1086\/651579","article-title":"Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models","volume":"201","author":"Bukh","year":"2010","journal-title":"J\u00a0Infect Dis"},{"key":"10.1053\/j.gastro.2013.11.009_bib16","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1073\/pnas.0510727103","article-title":"Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells","volume":"103","author":"Yi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2013.11.009_bib17","doi-asserted-by":"crossref","first-page":"17508","DOI":"10.1074\/jbc.M313020200","article-title":"In\u00a0vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms","volume":"279","author":"Lin","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1053\/j.gastro.2013.11.009_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.antiviral.2007.11.010","article-title":"Characterization of resistance mutations against HCV ketoamide protease inhibitors","volume":"77","author":"Tong","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1053\/j.gastro.2013.11.009_bib19","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1128\/AAC.01186-12","article-title":"Preclinical profile and characterization of the hepatitis C virus NS3 protease inhibitor asunaprevir (BMS-650032)","volume":"56","author":"McPhee","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2013.11.009_bib20","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1128\/AAC.01058-08","article-title":"In\u00a0vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitor","volume":"53","author":"Lin","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2013.11.009_bib21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1128\/AAC.00677-09","article-title":"MK-7009, a potent\u00a0and selective inhibitor of hepatitis C virus NS3\/4A protease","volume":"54","author":"Liverton","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl","key":"10.1053\/j.gastro.2013.11.009_bib22","doi-asserted-by":"crossref","first-page":"S302","DOI":"10.1016\/S0168-8278(10)60779-9","article-title":"Preclinical characterization of non covalent HCV NS3\/4A protease inhibitor BI201335","volume":"52","author":"White","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2013.11.009_bib23","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1128\/AAC.00324-12","article-title":"MK-5172, a selective inhibitor of hepatitis C virus NS3\/4a protease with broad activity across genotypes and resistant variants","volume":"56","author":"Summa","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2013.11.009_bib24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"10.1053\/j.gastro.2013.11.009_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature08960","article-title":"Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect","volume":"465","author":"Gao","year":"2010","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2013.11.009_bib26","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1128\/JVI.02177-10","article-title":"A\u00a0comprehensive structure-function comparison of hepatitis C virus strain JFH1 and J6 polymerases reveals a key residue stimulating replication in cell culture across genotypes","volume":"85","author":"Schmitt","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2013.11.009_bib27","doi-asserted-by":"crossref","first-page":"e1000885","DOI":"10.1371\/journal.ppat.1000885","article-title":"RNA polymerase activity and specific RNA structure are required for efficient HCV replication in cultured cells","volume":"6","author":"Murayama","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1053\/j.gastro.2013.11.009_bib28","doi-asserted-by":"crossref","first-page":"8030","DOI":"10.1128\/JVI.02088-06","article-title":"The NS3 helicase and NS5B-to-3\u2032X regions are important for efficient hepatitis C virus strain JFH-1 replication in Huh7 cells","volume":"81","author":"Murayama","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2013.11.009_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2012.09.033","article-title":"Development of robust hepatitis C virus genotype 4 subgenomic replicons","volume":"144","author":"Peng","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2013.11.009_bib30","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.3390\/v2112481","article-title":"The future of HCV therapy: NS4B as an antiviral target","volume":"2","author":"Dvory-Sobol","year":"2010","journal-title":"Viruses"},{"key":"10.1053\/j.gastro.2013.11.009_bib31","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jhep.2012.09.037","article-title":"Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options","volume":"58","author":"Suzuki","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2013.11.009_bib32","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2012.02.015","article-title":"Anti-hepatitis C virus drugs in development","volume":"142","author":"Schaefer","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2013.11.009_bib33","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1128\/JVI.02698-09","article-title":"Development of an intergenotypic hepatitis C virus (HCV) cell culture method to assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1 to 6","volume":"84","author":"Imhof","year":"2010","journal-title":"Virol"},{"key":"10.1053\/j.gastro.2013.11.009_bib34","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1053\/j.gastro.2007.08.005","article-title":"Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a\/2a (S52\/JFH1) viruses","volume":"133","author":"Gottwein","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2013.11.009_bib35","doi-asserted-by":"crossref","first-page":"7208","DOI":"10.1128\/JVI.01774-06","article-title":"In\u00a0vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells","volume":"81","author":"Sakai","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2013.11.009_bib36","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1073\/pnas.94.16.8738","article-title":"Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee","volume":"94","author":"Yanagi","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2013.11.009_bib37","doi-asserted-by":"crossref","first-page":"19757","DOI":"10.1073\/pnas.1218260109","article-title":"Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system","volume":"109","author":"Li","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2013.11.009_bib38","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1128\/JVI.02667-09","article-title":"Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in\u00a0vivo pathogenesis studies","volume":"84","author":"Gottwein","year":"2010","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2013.11.009_bib39","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1128\/AAC.01256-12","article-title":"Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells","volume":"56","author":"Saeed","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2013.11.009_bib40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.gastro.2012.09.017","article-title":"Replication of hepatitis C virus genotype 3a in cultured cells","volume":"144","author":"Saeed","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2013.11.009_bib41","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1053\/j.gastro.2011.06.004","article-title":"Differential Efficacy of Protease Inhibitors Against HCV Genotypes 2a, 3a, 5a, and 6a NS3\/4A Protease Recombinant Viruses","volume":"141","author":"Gottwein","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2013.11.009_bib42","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/593021","article-title":"Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection","volume":"198","author":"Jensen","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1053\/j.gastro.2013.11.009_bib43","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1053\/j.gastro.2010.11.036","article-title":"Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-alpha","volume":"140","author":"Scheel","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2013.11.009_bib44","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/hep.22673","article-title":"Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs","volume":"49","author":"Gottwein","year":"2009","journal-title":"Hepatology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508513016557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508513016557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:41:36Z","timestamp":1762162896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508513016557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0016508513016557"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2013.11.009","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Sensitivity of 5\u2032UTR-NS5A Recombinants of Hepatitis C\u00a0Virus Genotypes 1\u22126 to Protease and NS5A Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2013.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}